Amyris

Amyris, Inc. engages in the provision of bioscience solutions. It offers its products to the health and wellness, clean beauty, and flavor and fragrance markets. The company was founded by Jack D. Newman, Kinkead Keith Reiling, and Neil Renninger on July 17, 2003 and is headquartered in Emeryville, CA.

Earnings data Q1 2024

The principal business of Tara Gold Resources Corp. is the acquisition, exploration and development of high-quality precious metals projects with potential for economic commercial value. Tara Gold is currently focused on acquiring and developing properties in the natural resource belt of the Sierra Madre Occidental and other prolific areas in the states of Chihuahua, Sonora, and Sinaloa, Mexico.  Tara Gold provides investors growth exposure with a diversified exploration portfolio, multiple multi-million ounce targets and several near term production scenarios. Tara Gold owns equity positions in Cayden Resources Inc. (TSX-V: CYD) and Tara Minerals Corp. (TARM.OB), a public US company which explores and develops high-quality precious & non-precious metals and mineral projects in Mexico.

EMERYVILLE, Calif., Aug. 5, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced financial results for its second quarter ended June 30, 2021.

Amyris, Inc. Reports Second Quarter 2021 Financial Results

Cinemark Holdings

Livent Corp

Plug Power

Tupperware

The Dow Jones fell about 163 points, the S&P 500 dipped 0.4%, and the Nasdaq inched up just a bit. Find opportunities in today's market with the best short plays from Q.ai's deep learning algorithms.

AI Identifies Amyris Inc Among Today's Top Shorts

EMERYVILLE, Calif., Aug. 3, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that John Melo, President and Chief Executive Officer, will present at the Oppenheimer 24th Annual Technology, Internet & Communications Conference on Tuesday, August 10 th at 9:55 am ET.

Amyris to Present at the Oppenheimer 24th Annual Technology, Internet & Communications Conference on August 10, 2021

Nano-X Imaging

Renalytix AI plc

These potential stock rockets are well worth the different risks they present.

3 High-Growth Healthcare Stocks to Buy in August

Amyris, Inc. (AMRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will Amyris, Inc. (AMRS) Report Negative Earnings Next Week? What You Should Know

Amyris develops bio-based renewable alternatives to petrochemical and animal-based ingredients with a wide range of applications. The company is generating strong growth across a growing consumer brands business along with several licensing deals.

Amyris Stock Forecast For 2021: Where Is It Headed?

EMERYVILLE, Calif., July 22, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced a partnership with Naomi Watts to create a new consumer brand to provide science-backed, menopause wellness personal care products.

Amyris Partners With Naomi Watts To Launch Science-Backed Wellness Brand Focused On Menopause

EMERYVILLE, Calif., July 21, 2021 /PRNewswire/ --  Amyris, Inc., (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it will issue its financial results for the second quarter ended June 30, 2021 on the morning of Thursday, August 5, 2021, prior to the opening of the financial markets.

Amyris To Host Second Quarter 2021 Financial Results Conference Call On August 5

Shares of AMRS stock are on the move today as retail investors appear to be intrigued by this name, providing buying momentum. The post AMRS Stock: Why Biotech Stock Amyris Is Shooting Higher Today appeared first on InvestorPlace.

AMRS Stock: Why Biotech Stock Amyris Is Shooting Higher Today

Fluor

Blink Charging

Carvana

Markets started off the week right where they left off on Friday, with a sharp pullback at the open. Find opportunities with today's best short plays from Q.ai's artificial intelligence.

Fluor Corp Ranked Among Today's Top Shorts

National CineMedia

Redfin

The Dow, the S&P 500, and the Nasdaq are all in the red after a morning surge. Find opportunities in this market with today's best short plays from Q.ai's deep learning algorithms.

AI Identifies Carvana Co Among Today's Top Shorts

The S&P 500 is up more than 16% now this year and over 36% in the last 12 months. Make the most of this market with today's best short plays from Q.ai's artificial intelligence.

Artificial Intelligence Identifies Carvana Co Among Today's Top Shorts

EMERYVILLE, Calif., July 13, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer brands and a top supplier of sustainable and natural ingredients, today released its first Environmental, Social and Governance (ESG) report, underscoring the company's founding commitment to making people and the planet healthier.

Amyris Publishes Environmental, Social and Governance (ESG) Report and Sets ESG Impact Goals

Ocular Therapeutix

Shares of these overlooked gems could make investors very rich once the rest of the market notices their value.

3 Top Life Science Stocks to Buy on Sale Right Now

EMERYVILLE, Calif., July 1, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that it has signed an exclusive license with Nant Africa, LLC relating to the development and use of the RNA COVID vaccine Amyris developed in coordination with the Infectious Disease Research Institute (IDRI).

Amyris Completes First Major License For Leading RNA Vaccine Advancing Technology To Human Trials

Amyris: How Lead In Synthetic Biology Could Brew Up Big Profits

Arena Pharmaceuticals

Canopy Growth

Cronos Group

HEXO Corp

Innovative Industrial Properties

Coffee Holding

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry continues to take shape in 2021.

Breaking Down a Wild Week in the World of Weed Stocks

EMERYVILLE, Calif., June 17, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today announced partnerships with the UNCF (United Negro College Fund) and 10,000 Degrees ® to establish a $180,000 scholarship fund to support Black and African American students pursuing higher education across STEM (science, technology, engineering, and math), business, and marketing studies.

Amyris Partners with UNCF and 10,000 Degrees to Establish Scholarships

EMERYVILLE, Calif., June 16, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today announced that John Melo, President and Chief Executive Officer, will participate at the Jefferies Virtual Consumer Conference on Wednesday, June 23 rd at 3:15 pm ET.

Amyris to Present at the Jefferies Virtual Consumer Conference on June 23, 2021

EMERYVILLE, Calif., June 15, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that it has executed a binding term sheet for the acquisition of award-winning, clean wellness company OLIKA Inc. (OLIKA).

Amyris To Acquire OLIKA Consumer Brand, Expanding Family Of Clean Consumer Brands And Accelerating Growth

Amyris is a bio-manufacturer, producing alternative ingredients to be used in the production of beauty and wellness products, in addition to producing consumer goods. The company exhibits 47% growth in product revenues, has reduced debts, and its cash position has improved.

Finding Value In Beauty And Wellness Through Amyris

EMERYVILLE, Calif., June 2, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, today announced that John Melo, Director, President and Chief Executive Officer, will participate in a virtual fireside chat at the Morgan Stanley 6th Annual Sustainable Futures Conference on Wednesday, June 9 th at 3:30 pm ET.

Amyris to Present at the Virtual Morgan Stanley 6th Annual Sustainable Futures Conference on June 9, 2021

Hexcel

Las Vegas Sands

Jobless claims fell to yet another pandemic-era low, and cyclical stocks popped while the rotation out of tech continued for another day. Meanwhile, Q.ai's Artificial Intelligence systems have assessed each firm to find the best short plays.

Amyris Inc And Blink Charging Co Among Today's Top Shorts

Aemetis

Gevo

One of these things is (no longer) like the others.

Why Amyris, Gevo, and Aemetis Stocks Popped Wednesday

Kirby

The Dow Jones rose 70 points, the S&P 500 gained 0.3%, and the Nasdaq climbed 0.6%. Meanwhile, Q.ai's artificial intelligence has assessed each firm to find the best short plays of the day.

News for Amyris Stock (AMRS)